Mast cell deficiency improves cognition and enhances disease-associated microglia in 5XFAD mice DOI Creative Commons
Chih‐Chung Lin, Fanny Hérisson, Hoang Le

и другие.

Cell Reports, Год журнала: 2023, Номер 42(9), С. 113141 - 113141

Опубликована: Сен. 1, 2023

Emerging evidence suggests that peripheral immune cells contribute to Alzheimer's disease (AD) neuropathogenesis. Among these, mast are known for their functions in allergic reactions and neuroinflammation; however, little is about role AD. Here, we crossed 5XFAD mice with cell-deficient strains observed the effects on AD-related neuropathology cognitive impairment. We found cell depletion improved contextual fear conditioning without affecting cued conditioning, anxiety-like behavior, or amyloid burden. Furthermore, led an upregulation of transcriptomic signatures putatively protective disease-associated microglia resulted reduced markers indicative reactive astrocytes. hypothesize a system bidirectional communication between dural brain, where respond signals from brain environment by expressing immune-regulatory mediators, impacting cognition glial function. These findings highlight as potential therapeutic targets

Язык: Английский

Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle DOI
Jens V. Andersen, Arne Schousboe, Alexei Verkhratsky

и другие.

Progress in Neurobiology, Год журнала: 2022, Номер 217, С. 102331 - 102331

Опубликована: Июль 21, 2022

Язык: Английский

Процитировано

160

Targeting neuroinflammation in Alzheimer’s disease: from mechanisms to clinical applications DOI Creative Commons

Yu Liu,

Zizhen Si,

Chen-Jun Zou

и другие.

Neural Regeneration Research, Год журнала: 2022, Номер 18(4), С. 708 - 708

Опубликована: Сен. 21, 2022

Alzheimer's disease is characterized by sustained neuroinflammation leading to memory loss and cognitive decline. The past decade has witnessed tremendous efforts in research; however, no effective treatment available prevent progression. An increasing body of evidence suggests that plays an important role pathogenesis, alongside the classical pathological hallmarks such as misfolded aggregated proteins (e.g., amyloid-beta tau). Firstly, this review summarized clinical characteristics disease. Secondly, we outlined key aspects glial cell-associated inflammation pathogenesis provided latest on roles microglia astrocytes pathology. Then, revealed double-edged nature inflammatory cytokines inflammasomes In addition, potential therapeutic innate immunity for were also discussed through these mechanisms. final section, remaining problems according current research status discussed.

Язык: Английский

Процитировано

113

Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation DOI Creative Commons
Giulia Di Benedetto, Chiara Burgaletto, Carlo Maria Bellanca

и другие.

Cells, Год журнала: 2022, Номер 11(17), С. 2728 - 2728

Опубликована: Сен. 1, 2022

Alzheimer’s disease (AD) is the most common form of dementia worldwide, with a complex, poorly understood pathogenesis. Cerebral atrophy, amyloid-β (Aβ) plaques, and neurofibrillary tangles represent main pathological hallmarks AD brain. Recently, neuroinflammation has been recognized as prominent feature brain substantial evidence suggests that inflammatory response modulates progression. Additionally, dysregulation calcium (Ca2+) homeostasis represents another early factor involved in pathogenesis, intracellular Ca2+ concentration essential to ensure proper cellular neuronal functions. Although growing supports involvement mechanisms neurodegeneration-related processes, scant data are available on its contribution microglia astrocytes functioning, both health throughout continuum. Nevertheless, AD-related aberrant signalling crucially underpinning neuroinflammatory processes that, turn, impact function. In this light, we attempted provide an overview current understanding interactions between glia cells-mediated responses molecular AD.

Язык: Английский

Процитировано

89

Dual-3DM3AD: Mixed Transformer Based Semantic Segmentation and Triplet Pre-Processing for Early Multi-Class Alzheimer’s Diagnosis DOI Creative Commons
Arfat Ahmad Khan, Rakesh Kumar Mahendran,

P Kumar

и другие.

IEEE Transactions on Neural Systems and Rehabilitation Engineering, Год журнала: 2024, Номер 32, С. 696 - 707

Опубликована: Янв. 1, 2024

Alzheimer's Disease (AD) is a widespread, chronic, irreversible, and degenerative condition, its early detection during the prodromal stage of utmost importance. Typically, AD studies rely on single data modalities, such as MRI or PET, for making predictions. Nevertheless, combining metabolic structural can offer comprehensive perspective staging analysis. To address this goal, paper introduces an innovative multi-modal fusion-based approach named Dual-3DM 3 -AD. This model proposed accurate diagnosis by considering both PET image scans. Initially, we pre-process images in terms noise reduction, skull stripping 3D conversion using Quaternion Non-local Means Denoising Algorithm (QNLM), Morphology function Block Divider Model (BDM), respectively, which enhances quality. Furthermore, have adapted Mixed-transformer with Furthered U-Net performing semantic segmentation minimizing complexity. -AD consisted multi-scale feature extraction module extracting appropriate features from segmented images. The extracted are then aggregated Densely Connected Feature Aggregator Module (DCFAM) to utilize features. Finally, multi-head attention mechanism dimensionality softmax layer applied multi-class diagnosis. compared several baseline approaches help performance metrics. final results unveil that work achieves 98% accuracy, 97.8% sensitivity, 97.5% specificity, 98.2% f-measure, better ROC curves, outperforms other existing models multiclass

Язык: Английский

Процитировано

34

Unveiling the role of astrocytes in postoperative cognitive dysfunction DOI
Liang He,

X. Duan,

Shikuo Li

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 95, С. 102223 - 102223

Опубликована: Фев. 5, 2024

Язык: Английский

Процитировано

22

Emerging roles of N-linked glycosylation in brain physiology and disorders DOI
Lindsey R. Conroy, Tara R. Hawkinson, Lyndsay E.A. Young

и другие.

Trends in Endocrinology and Metabolism, Год журнала: 2021, Номер 32(12), С. 980 - 993

Опубликована: Окт. 29, 2021

Язык: Английский

Процитировано

64

TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications DOI Creative Commons
Jian Luo

Biomedicines, Год журнала: 2022, Номер 10(5), С. 1206 - 1206

Опубликована: Май 23, 2022

Astrocytes are essential for normal brain development and functioning. They respond to injury disease through a process referred as reactive astrogliosis, where the reactivity is highly heterogenous context-dependent. Reactive astrocytes active contributors pathology can exert beneficial, detrimental, or mixed effects following insults. Transforming growth factor-β (TGF-β) has been identified one of key factors regulating astrocyte reactivity. The genetic pharmacological manipulation TGF-β signaling pathway in animal models central nervous system (CNS) alters pathological functional outcomes. This review aims provide recent understanding regarding injury, aging, neurodegeneration. Further, it explores how modulates function context CNS injury.

Язык: Английский

Процитировано

63

Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives DOI Creative Commons
Shan Huang, Yan‐Jiang Wang, Junhong Guo

и другие.

Neuroscience Bulletin, Год журнала: 2022, Номер 38(6), С. 677 - 691

Опубликована: Март 19, 2022

Abstract Since the establishment of biomarker-based A-T-N (Amyloid/Tau/Neurodegeneration) framework in Alzheimer’s disease (AD), diagnosis AD has become more precise, and cerebrospinal fluid tests positron emission tomography examinations based on this have widely accepted. However, does not encompass whole spectrum pathologies, problems with invasiveness high cost limit application above diagnostic methods aimed at central nervous system. Therefore, we suggest addition an “X” to a focus peripheral biomarkers AD. In review, retrospectively describe recent progress A-T-N-X framework, analyze problems, present our perspectives

Язык: Английский

Процитировано

45

Adult neurogenesis in Alzheimer's disease DOI
Se Hoon Choi, Rudolph E. Tanzi

Hippocampus, Год журнала: 2023, Номер 33(4), С. 307 - 321

Опубликована: Фев. 7, 2023

Abstract Alzheimer's disease (AD) is the most common form of age‐related dementia, characterized by progressive memory loss and cognitive disturbances. The hippocampus, where adult hippocampal neurogenesis (AHN), a relatively novel brain plasticity that refers to birth new neurons, occurs, one first regions be affected in AD patients. Recent studies showed AHN persists throughout life humans, but it drops sharply Next questions consider would whether impairment contributing factor learning restoring could ameliorate or delay dysfunction. Here, we outline discuss current knowledge about state patients, as potentially relevant mechanism underlying deficits AD, therapeutic potential activating mechanisms AD.

Язык: Английский

Процитировано

38

Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains DOI Open Access
Zheng Shen, Zhengyang Li, Mengting Yu

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2023, Номер 158, С. 114206 - 114206

Опубликована: Янв. 5, 2023

The term type III diabetes (T3DM) has been proposed for Alzheimer's disease (AD) due to the shared molecular and cellular features between 2 (T2DM) insulin resistance-associated memory deficits cognitive decline in elderly individuals. Astrocytes elicit neuroprotective or deleterious effects AD progression severity. Patients with T2DM are at a high risk of impairment, targeting astrocytes might be promising alleviating neurodegeneration diabetic brain. Recent studies focusing on cell-specific activities brain have revealed important role metabolism (e.g., glucose metabolism, lipid metabolism), neurovascular coupling, synapses, synaptic plasticity. In this review, we discuss how their dysfunction result multiple pathological clinical from metabolic perspective potential comorbid mechanism these two diseases astrocytes.

Язык: Английский

Процитировано

34